Peak 8 Properties LLC
Overview
Peak 8 Properties LLC sponsors a self-funded health plan that covered 643 participants in plan year 2025, up 5% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, death benefits.
- Plan type
- ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
- Participants
- 643 · prior year 612
- Plan year
- Begins January 1 · next renewal January 2027
- Health plans filed
- Peak 8 Properties, LLC DBA Breckenridge Grand Vacations Employee Benefits Plan, plan 502 (643 participants)
- Broker compensation
- $2K across insured contracts
Insurance carriers
Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.
| Carrier | Coverage | Covered | Premium | Broker comp |
|---|---|---|---|---|
| Hartford Life and Accident | Life | 643 | $39K | $2K |
| Metropolitan Life Insurance Company | Vision | 788 | $31K | $463 |
Pharmacy benefit estimate
StreamRX estimate for a plan this size. Not based on this plan's claims.
Estimated prescription spend: 643 participants × $2,371 national average per member. Usually higher once dependents are counted.
Typical savings opportunity found in independent reviews of plans this size.
Form 5500 filing details
- Filing
- Form 5500 with Schedule A, plan year 2025
- Plan sponsor
- Peak 8 Properties LLC
- Sponsor EIN
- 46-0753714
- Plan number
- 502
- Filed with
- U.S. Department of Labor (EBSA) via EFAST2
Verify this filing: search EIN 46-0753714 in the Department of Labor's EFAST2 Form 5500 search.
About this data
Source: Peak 8 Properties LLC's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Peak 8 Properties LLC.